“tirzepatide weight loss” gets about 27.1k searches a month in the US. The top results are zepbound.lilly.com, goodrx.com, mediweightloss.com. The median Domain Rating on page one is DR 85, and the lowest is DR 44. To rank, you need relevant backlinks from sites like these.
92 organic results· Google estimates ~129
Tirzepatide is a prescription once-weekly injection that helps with significant weight loss by mimicking two natural gut hormones—GLP-1 and GIP—to reduce appetite and slow stomach emptying. It is approved for chronic weight management under the brand name Zepbound and for type 2 diabetes under the name Mounjaro.
Appetite control: It signals the brain to reduce hunger and cravings. Delayed digestion: It slows down how fast food leaves your stomach so you feel full longer. Blood sugar support: It helps the pancreas release insulin after meals to manage glucose levels.
Clinical trials show that adults taking the highest weekly dose lose an average of 15% to 21% of their starting body weight over 72 weeks (about 16.5 months). This typically amounts to a loss of 34 to 48 pounds, with higher doses yielding greater results.
Gastrointestinal issues: Nausea, vomiting, diarrhea, and constipation are the most frequent effects. General fatigue: Some people experience mild tiredness or headaches as their body adjusts.
It is generally prescribed for adults with a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 plus a weight-related condition like high blood pressure or high cholesterol. It should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
If you're considering this option, would you like to discuss common dosage schedules, pricing/insurance coverage details, or tips for managing side effects ?
Sign up free to see all 100 results and find which domains are already selling links. Skip the guesswork and rank faster.
See All Results. It's Free.